Boundless Bio Inc (BOLD)

Apr 03, 2025

Boundless Bio stock plunges to 52-week low of $1.41 - Investing.com

Apr 03, 2025

Apr 03, 2025

Boundless Bio to Participate in the Needham Virtual Healthcare Conference - TradingView

Apr 03, 2025

Apr 01, 2025

Boundless Bio plans $14.5M stock sale via Jefferies By Investing.com - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

Boundless Bio plans $14.5M stock sale via Jefferies - Investing.com India

Apr 01, 2025

Apr 01, 2025

Boundless Bio Inc Files For Mixed Shelf Of Up To $400 MillionSEC Filing - MarketScreener

Apr 01, 2025

Mar 29, 2025

Boundless Bio’s 2024 Financial Results and Strategic Progress - MSN

Mar 29, 2025

Mar 28, 2025

Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace

Mar 28, 2025

Mar 27, 2025

Boundless Bio Inc. (BOLD) reports earnings - Quartz

Mar 27, 2025

Mar 27, 2025

Boundless Bio Reports Fourth Quarter And Full Year 2024 Financial Results And Business Highlights - Marketscreener.com

Mar 27, 2025

Mar 27, 2025

Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - The Manila Times

Mar 27, 2025

Mar 27, 2025

Boundless Bio's $152M War Chest Fuels Breakthrough Cancer Drug Development - Stock Titan

Mar 27, 2025

Mar 06, 2025

Here's Why We're Watching Boundless Bio's (NASDAQ:BOLD) Cash Burn Situation - Yahoo Finance

Mar 06, 2025

Feb 26, 2025

What Will Boundless Bio Reveal at the Leerink Conference? CEO Set for Key Presentation - StockTitan

Feb 26, 2025

Feb 07, 2025

J&J vet jumps to Affinia—Chutes & Ladders - Fierce Biotech

Feb 07, 2025

Feb 04, 2025

Francisco Ballester to retire from Sandoz - BioCentury

Feb 04, 2025

Feb 03, 2025

Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer -February 03, 2025 at 10:00 am EST - Marketscreener.com

Feb 03, 2025

Feb 03, 2025

Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer - The Manila Times

Feb 03, 2025

Feb 03, 2025

Oncology Drug Development Expert Behind TRK Inhibitors Joins Boundless Bio as CMO - StockTitan

Feb 03, 2025

Jan 23, 2025

Beta Bionics targets IPO of up to $120M - BioWorld Online

Jan 23, 2025

Jan 17, 2025

Apellis COO stepping down to take first CEO job—Chutes & Ladders - Fierce Biotech

Jan 17, 2025

Jan 14, 2025

Neomorph Announces Appointment of Dr. Klaus Wagner, M.D., Ph.D. as Chief Medical Officer - BioSpace

Jan 14, 2025

Jan 14, 2025

Neomorph Appoints Dr. Klaus Wagner as Chief Medical Officer - citybiz

Jan 14, 2025

Jan 14, 2025

Biopharma IPOs rebound slightly, as class of 2024 lags with a 29% average decline - BioWorld Online

Jan 14, 2025

Jan 10, 2025

January Effect Builds Up Momentum: 5 Small-Cap Stocks to Buy - MSN

Jan 10, 2025

Jan 10, 2025

Terremoto Biosciences Appoints James Christensen, Ph.D., as President and Head of Research & Development - Business Wire

Jan 10, 2025

Jan 02, 2025

Finance Watch: As Cash Dwindles, Biotechs Cut Costs, Sell Assets, Merge, Assess Options - News & Insights

Jan 02, 2025

Jan 02, 2025

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Jan 02, 2025

Dec 31, 2024

Layoffs Continued Across Biopharma in 2024 - BioSpace

Dec 31, 2024

Dec 19, 2024

The Escalator: Boundless Bio, Intelliguard, Klick Health and more - MM+M Online

Dec 19, 2024

Dec 14, 2024

Guggenheim Downgrades Boundless Bio (BOLD) - MSN

Dec 14, 2024

Dec 13, 2024

Genesis hires Shifeng Pan as CSO, names Paul Friedman chair - BioCentury

Dec 13, 2024

Dec 12, 2024

Boundless Bio, Inc. Changes to Management Team - Marketscreener.com

Dec 12, 2024

Dec 12, 2024

Boundless Bio Won't Advance Cancer Treatment Trial, Executives to Step Down - MarketWatch

Dec 12, 2024

Dec 12, 2024

Boundless Bio Announces Pipeline and Leadership Updates - The Manila Times

Dec 12, 2024

Dec 06, 2024

Costco Wholesale (COST-Q) QuotePress Release - The Globe and Mail

Dec 06, 2024

Dec 04, 2024

Vertex Global reports ten IPOs, acquisitions worldwide in 2024 - Tech in Asia

Dec 04, 2024

Nov 26, 2024

Boundless Bio, Inc. (BOLD) Loses -19.52% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN

Nov 26, 2024

Nov 21, 2024

Amgen names Howard Chang head of research and CSO - BioCentury

Nov 21, 2024

Nov 20, 2024

Amgen names Stanford geneticist and biotech founder to CSO post - Endpoints News

Nov 20, 2024

Nov 13, 2024

Science Spotlight: How extrachromosomal DNA drives cancer - BioCentury

Nov 13, 2024

Nov 13, 2024

Extrachromosomal DNA acts as joker for cancer cells - BioWorld Online

Nov 13, 2024

Nov 11, 2024

Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews

Nov 11, 2024

Nov 10, 2024

Stanford Scientists Overturn Mendel’s Law With Shocking Cancer Discovery - SciTechDaily

Nov 10, 2024

Nov 06, 2024

Stanford researchers unveil the key role of extrachromosomal DNA in cancer - News-Medical.Net

Nov 06, 2024

Nov 05, 2024

Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference - The Manila Times

Nov 05, 2024